Business
The CMM platform renders real-time, continuous molecular-level insights that help inform dosing decisions.
The medical device company has signed an MoU with DHI 2048 to deploy 2,500 systems to the region by the year 2025.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The company uses machine learning to detect, monitor and treat chronic and long-term health conditions.
The new acquisition is set to give K Health more behavioral health capabilities.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
Ginger’s CEO Russell Glass will take over as CEO of Headspace Health, and Headspace CEO CeCe Morken will continue to serve as Headspace CEO and president of the combined company.
The platform lets patients with rare diseases access their medical data and participate in research studies.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.
Funding will be used towards scaling the platform, focusing on product development and expansion across the Kingdom and the rest of the GCC region.